Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 25;4(2):29.
doi: 10.3390/healthcare4020029.

Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk

Affiliations
Review

Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk

Elizabeth Huber et al. Healthcare (Basel). .

Abstract

Beginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, "Who is at risk of opioid misuse?" should evolve to, "Who may benefit from COT?" in light of the current evidence.

Keywords: biopsychosocial approach; chronic low back pain; chronic opioid therapy; chronic pain; opioids.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Catan T., Perez E. A Pain-Drug Champion Has Second Thoughts. [(accessed on 17 December 2012)]. Available online: http://www.thblack.com/links/RSD/A%20Pain-Drug%20Champion%20Has%20Second....
    1. Bennett D.S., Carr D.B. Opiophobia as a barrier to the treatment of pain. J. Pain Palliat. Care Pharmacother. 2002;16:105–109. doi: 10.1080/J354v16n01_09. - DOI - PubMed
    1. Robinson R.C., Gatchel R.J., Polatin P.B., Deschner M., Gajraj N., Noe C. Screening for problematic opioid behavior. Clin. J. Pain. 2001;17:220–228. doi: 10.1097/00002508-200109000-00006. - DOI - PubMed
    1. Adams L.L., Gatchel R.J., Robinson R.C., Polatin P., Gajraj N., Deschner M., Noe C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J. Pain Symptom Manag. 2004;27:440–459. doi: 10.1016/j.jpainsymman.2003.10.009. - DOI - PubMed
    1. Butler S.F., Fernandez K., Benoit C., Budman S.H., Jamison R.N. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R) Pain. 2008;9:360–372. doi: 10.1016/j.jpain.2007.11.014. - DOI - PMC - PubMed

LinkOut - more resources